Exhibit 99.1

Allegro MicroSystems Reports First Quarter 2027 Results

First Quarter Sales Increased by 27% Year-over-Year to $259 Million

 

Manchester, NH, July 30, 2026 – Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its first quarter ended June 26, 2026.

 

“We began fiscal 2027 with strong momentum, delivering our sixth consecutive quarter of sales growth. Fiscal first quarter sales were $259 million, representing a 27% increase year-over-year. GAAP earnings per share improved to $0.08 in fiscal first quarter 2027 from a $0.07 loss per share in fiscal first quarter 2026. Non-GAAP EPS grew for the fifth consecutive quarter to $0.23, increasing more than 2.5x over the first quarter of fiscal 2026. These results were led by data center, which reached a record 17% of total sales, and by continued strength in xEV and ADAS,” said Mike Doogue, President and CEO of Allegro MicroSystems. “Our market leading products and technology sit at the intersection of AI, electrification, and automation — the defining megatrends powering growth across our Auto and Industrial end markets. Increasing bookings and an expanding backlog strengthen our confidence in our strategy and growth potential.”

 

First Quarter Financial Highlights:

In thousands, except per share data

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

March 27, 2026

 

 

June 27, 2025

 

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

Net Sales

 

 

 

 

 

 

 

 

 

Automotive

 

$

165,349

 

 

$

163,909

 

 

$

144,264

 

Industrial and Other

 

 

93,894

 

 

 

79,278

 

 

 

59,141

 

Total net sales

 

$

259,243

 

 

$

243,187

 

 

$

203,405

 

GAAP Financial Measures

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

48.5

%

 

 

47.0

%

 

 

44.9

%

Operating margin %

 

 

9.8

%

 

 

2.2

%

 

 

(1.3

)%

Diluted EPS

 

$

0.08

 

 

$

(0.09

)

 

$

(0.07

)

Non-GAAP Financial Measures

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

51.1

%

 

 

50.0

%

 

 

48.2

%

Operating margin %

 

 

19.4

%

 

 

15.6

%

 

 

11.1

%

Diluted EPS

 

$

0.23

 

 

$

0.17

 

 

$

0.09

 

Business Outlook

For the second quarter of fiscal year 2027 ending September 25, 2026, the Company expects total net sales to be in the range of
$265 million to $275 million. At the midpoint of this range, it implies growth in net sales of 26% year-over-year.

The Company also estimates the following results on a non-GAAP basis:

Gross Margin is expected to be between 50.75% and 51.75%,
Operating expenses are expected to be $84.5 million, plus or minus $1 million, and
Diluted Earnings per Share is expected to be between $0.23 and $0.26, with the mid-point of this range implying an 88% year-over-year increase.

 

Allegro has not provided a reconciliation of its second fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Operating Expenses, and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles (“GAAP”) measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.


Earnings Webcast

A webcast will be held on Thursday, July 30, 2026 at 8:30 a.m., Eastern Time. Michael C. Doogue, President and Chief Executive Officer, and Derek P. D’Antilio, Executive Vice President and Chief Financial Officer, will discuss Allegro’s business and financial results.

The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

About Allegro MicroSystems

Allegro MicroSystems, Inc. is leveraging more than three decades of expertise in magnetic sensing and power ICs to propel electrification, automation, AI data center, and robotics forward with solutions that enhance efficiency, performance and sustainability. Allegro’s commitment to quality drives transformation across industries, reinforcing our status as a pioneer in “automotive-grade” technology and a partner in our customers’ success. For additional information, please visit https://www.allegromicro.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors and trends affecting our business, including the projected size and growth of markets in which we operate or may operate, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “would,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements.

Forward-looking statements are based on our management’s current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 27, 2026, as any such factors may be updated from time to time in our Quarterly Reports on Form 10-Q and our other filings with the Securities and Exchange Commission (the “SEC”). These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; any failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; the cyclical nature of the semiconductor industry, including the analog segment in which we compete; any downturn or disruption in the automotive market or industry; our ability to successfully integrate the acquisition of other companies or technologies and products into our business; our ability to maintain or improve our gross margins may be adversely affected by decreases in average selling prices of our products, increases in input costs or shifts in product, customer or channel mix; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results and meet the expectations of investors; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; events beyond our control, including conflicts in the Middle East, impacting us, our key suppliers or our manufacturing partners or other third-party suppliers of components, materials or subassemblies; our ability to develop new product features or new products in a timely and cost-effective manner; our dependence on growth in the end markets that use our products, and the impact that slowdowns in such growth, including as a result of volatility in demand for emerging technologies or changes in government incentives, could have on our financial results; the loss of one or more significant customers; our ability to identify, enter and expand in new markets, and to generate returns on such investments; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; risks, liabilities, costs and obligations related to governmental regulations and other legal obligations, including export/trade control, privacy, data protection, information security, cybersecurity, consumer protection, environmental and occupational health and safety, antitrust, anti-corruption and anti-bribery, product safety, environmental protection, employment matters and tax; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit


our flexibility to operate our business; our ability to retain key and highly skilled personnel; the impact on the market price of our common stock from future sales of our common stock by large stockholders, or the perception that such sales could occur; the impact of restructuring activities on our business and operating results; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or confidential information or those of our third-party service providers; the risks presented by the use of artificial intelligence, machine learning and automated decision-making technologies by us and others; any failure to maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

This press release includes certain non-GAAP financial measures as defined by the SEC rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their most directly comparable GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

This press release may not be reproduced, forwarded to any person or published, in whole or in part.


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share amounts)

(Unaudited)

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

June 27, 2025

 

Net sales

 

$

259,243

 

 

$

203,405

 

Cost of goods sold

 

 

133,633

 

 

 

112,103

 

Gross profit

 

 

125,610

 

 

 

91,302

 

Operating expenses:

 

 

 

 

 

 

Research and development

 

 

55,168

 

 

 

46,500

 

Selling, general and administrative

 

 

44,975

 

 

 

47,542

 

Total operating expenses

 

 

100,143

 

 

 

94,042

 

Operating income (loss)

 

 

25,467

 

 

 

(2,740

)

Interest and other expense

 

 

(8,042

)

 

 

(7,253

)

Income (loss) before income taxes

 

 

17,425

 

 

 

(9,993

)

Income tax provision

 

 

1,506

 

 

 

3,169

 

Net income (loss)

 

 

15,919

 

 

 

(13,162

)

Net income attributable to non-controlling interests

 

 

48

 

 

 

65

 

Net income (loss) attributable to Allegro MicroSystems, Inc.

 

$

15,871

 

 

$

(13,227

)

Net income (loss) per common share attributable to Allegro MicroSystems, Inc.:

 

 

 

 

 

 

Basic

 

$

0.09

 

 

$

(0.07

)

Diluted

 

$

0.08

 

 

$

(0.07

)

Weighted average shares outstanding:

 

 

 

 

 

 

Basic

 

 

185,806,543

 

 

 

184,587,027

 

Diluted

 

 

187,770,061

 

 

 

184,587,027

 

 

Supplemental Schedule of Total Net Sales

The following table summarizes total net sales by market within the Company’s unaudited condensed consolidated statements of operations:

 

Three-Month Period Ended

 

 

Change

 

 

June 26, 2026

 

 

June 27, 2025

 

 

Amount

 

 

%

 

 

(Dollars in thousands)

 

Automotive

 

$

165,349

 

 

$

144,264

 

 

$

21,085

 

 

 

15

%

Industrial and Other

 

 

93,894

 

 

 

59,141

 

 

 

34,753

 

 

 

59

%

Total net sales

 

$

259,243

 

 

$

203,405

 

 

$

55,838

 

 

 

27

%

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

June 26,

 

 

March 27,

 

 

2026
(Unaudited)

 

 

2026

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

162,029

 

 

$

168,753

 

Restricted cash

 

 

8,444

 

 

 

6,604

 

Trade accounts receivable, net

 

 

98,661

 

 

 

93,248

 

Inventories

 

 

188,064

 

 

 

181,752

 

Prepaid income taxes

 

 

714

 

 

 

1,179

 

Related party - other current assets

 

 

11,250

 

 

 

 

Prepaid expenses and other current assets

 

 

38,883

 

 

 

52,070

 

Total current assets

 

 

508,045

 

 

 

503,606

 

Property, plant and equipment, net

 

 

304,336

 

 

 

308,258

 

Deferred income tax assets

 

 

81,776

 

 

 

80,221

 

Goodwill

 

 

203,057

 

 

 

203,291

 

Intangible assets, net

 

 

232,855

 

 

 

238,675

 

Equity investment in related party

 

 

18,687

 

 

 

22,296

 

Related party - other assets

 

 

18,750

 

 

 

15,000

 

Other assets

 

 

44,456

 

 

 

44,828

 

Total assets

 

$

1,411,962

 

 

$

1,416,175

 

Liabilities, Non-Controlling Interest and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Trade accounts payable

 

$

57,826

 

 

$

44,438

 

Amounts due to related party

 

 

4,607

 

 

 

4,794

 

Accrued expenses and other current liabilities

 

 

73,276

 

 

 

95,163

 

Current portion of long-term debt

 

 

1,499

 

 

 

1,530

 

Total current liabilities

 

 

137,208

 

 

 

145,925

 

Long-term debt

 

 

285,660

 

 

 

285,746

 

Other long-term liabilities

 

 

23,132

 

 

 

28,059

 

Total liabilities

 

 

446,000

 

 

 

459,730

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

Preferred stock

 

 

 

 

 

 

Common stock

 

 

1,863

 

 

 

1,854

 

Additional paid-in capital

 

 

1,046,867

 

 

 

1,050,582

 

Accumulated deficit

 

 

(52,617

)

 

 

(68,488

)

Accumulated other comprehensive loss

 

 

(31,837

)

 

 

(29,201

)

Equity attributable to Allegro MicroSystems, Inc.

 

 

964,276

 

 

 

954,747

 

Non-controlling interest

 

 

1,686

 

 

 

1,698

 

Total stockholders’ equity

 

 

965,962

 

 

 

956,445

 

Total liabilities, non-controlling interest and stockholders’ equity

 

$

1,411,962

 

 

$

1,416,175

 

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

June 27, 2025

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income (loss)

 

$

15,919

 

 

$

(13,162

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

16,867

 

 

 

16,216

 

Amortization of deferred financing costs

 

 

297

 

 

 

933

 

Deferred income taxes

 

 

(1,702

)

 

 

(5,061

)

Stock-based compensation

 

 

14,128

 

 

 

10,762

 

Provisions for inventory and expected credit losses

 

 

1,555

 

 

 

3,450

 

Other non-cash reconciling items

 

 

(14

)

 

 

(58

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

Trade accounts receivable

 

 

(5,413

)

 

 

(5,332

)

Inventories

 

 

(7,870

)

 

 

7,233

 

Payments to related party

 

 

(15,000

)

 

 

 

Prepaid expenses and other assets

 

 

15,515

 

 

 

35,965

 

Trade accounts payable

 

 

13,754

 

 

 

6,281

 

Due to and from related parties

 

 

(188

)

 

 

(3,633

)

Other changes in operating assets and liabilities, net

 

 

(25,859

)

 

 

8,024

 

Net cash provided by operating activities

 

 

21,989

 

 

 

61,618

 

Cash flows from investing activities:

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(8,017

)

 

 

(10,600

)

Net cash used in investing activities

 

 

(8,017

)

 

 

(10,600

)

Cash flows from financing activities:

 

 

 

 

 

 

Repayment of term loan

 

 

 

 

 

(35,000

)

Finance lease payments

 

 

(237

)

 

 

(202

)

Payments for taxes related to net share settlement of equity awards

 

 

(17,757

)

 

 

(8,988

)

Net cash used in financing activities

 

 

(17,994

)

 

 

(44,190

)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

 

(862

)

 

 

1,444

 

Net (decrease) increase in cash and cash equivalents and restricted cash

 

 

(4,884

)

 

 

8,272

 

Cash and cash equivalents and restricted cash at beginning of period

 

 

175,357

 

 

 

131,107

 

Cash and cash equivalents and restricted cash at end of period

 

$

170,473

 

 

$

139,379

 

 


Non-GAAP Financial Measures

In addition to the measures presented in our condensed consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP Profit before Tax, non-GAAP Income Tax Provision, non-GAAP Effective Tax Rate, non-GAAP Net Income Attributable to Allegro MicroSystems, Inc, non-GAAP Basic and Diluted Earnings per Share, non-GAAP Free Cash Flow, and non-GAAP Free Cash Flow as a percentage of net sales (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Income Tax Provision (Benefit), management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Income Tax Provision (Benefit) across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures, such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges, such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These Non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related-party activities and other non-operational costs.

Non-GAAP Income Tax Provision

In calculating the non-GAAP Income Tax Provision, we adjust for the tax effect of adjustments to GAAP results which represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described below. We also adjust for any discrete tax items and the impact of non-recurring tax law changes to ensure the non-GAAP Income Tax Rate (“NG ETR”) reflects future operations.

Our fiscal year 2026 and 2027 NG ETR excludes the impact of the 2025 One Big Beautiful Bill Act’s one-time research and development amortization election which accelerates the amortization of previously capitalized domestic research and development over a two-year period. The NG ETR is applied to non-GAAP Profit before Tax to arrive at the tax effect of adjustments to GAAP results.

 

Reconciliation of Non-GAAP Gross Profit and Non-GAAP Gross Margin

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

March 27, 2026

 

 

June 27, 2025

 

 

(Dollars in thousands)

 

GAAP Gross Profit

 

$

125,610

 

 

$

114,275

 

 

$

91,302

 

GAAP Gross Margin (% of net sales)

 

 

48.5

%

 

 

47.0

%

 

 

44.9

%

 

 

 

 

 

 

 

 

 

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

Purchased intangible amortization

 

 

5,089

 

 

 

5,089

 

 

 

5,089

 

Restructuring costs

 

 

83

 

 

 

723

 

 

 

705

 

Stock-based compensation(1)

 

 

1,172

 

 

 

1,033

 

 

 

888

 

Other costs

 

 

428

 

 

 

442

 

 

 

 

Total Non-GAAP Adjustments

 

$

6,772

 

 

$

7,287

 

 

$

6,682

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Gross Profit

 

$

132,382

 

 

$

121,562

 

 

$

97,984

 

Non-GAAP Gross Margin (% of net sales)

 

 

51.1

%

 

 

50.0

%

 

 

48.2

%

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP stock-based compensation charges are stock-based compensation expense and related payroll tax effects.

 

 


 

Reconciliation of Non-GAAP Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

March 27, 2026

 

 

June 27, 2025

 

 

(Dollars in thousands)

 

GAAP Operating Expenses

 

$

100,143

 

 

$

108,865

 

 

$

94,042

 

 

 

 

 

 

 

 

 

 

 

Research and Development Expenses

 

 

 

 

 

 

 

 

 

GAAP Research and Development Expenses

 

 

55,168

 

 

 

55,535

 

 

 

46,500

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

Purchased intangible amortization

 

 

6

 

 

 

6

 

 

 

3

 

Restructuring costs

 

 

134

 

 

 

1,674

 

 

 

1,131

 

Stock-based compensation(1)

 

 

6,613

 

 

 

4,385

 

 

 

2,911

 

Other costs(2)

 

 

514

 

 

 

956

 

 

 

35

 

Non-GAAP Research and Development Expenses

 

 

47,901

 

 

 

48,514

 

 

 

42,420

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

 

 

 

 

 

 

 

GAAP Selling, General and Administrative Expenses

 

 

44,975

 

 

 

46,740

 

 

 

47,542

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

9

 

 

 

496

 

 

 

130

 

Purchased intangible amortization

 

 

535

 

 

 

558

 

 

 

535

 

Restructuring costs

 

 

443

 

 

 

2,630

 

 

 

1,184

 

Stock-based compensation(1)

 

 

9,420

 

 

 

5,229

 

 

 

6,963

 

Other costs(2)

 

 

487

 

 

 

2,628

 

 

 

5,838

 

Non-GAAP Selling, General and Administrative Expenses

 

 

34,081

 

 

 

35,199

 

 

 

32,892

 

 

 

 

 

 

 

 

 

 

 

Impairment of assets held for sale

 

 

 

 

 

6,590

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Non-GAAP Adjustments

 

 

18,161

 

 

 

25,152

 

 

 

18,730

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Expenses

 

$

81,982

 

 

$

83,713

 

 

$

75,312

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP stock-based compensation charges are stock-based compensation expense and related payroll tax effects.

 

(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 

 

Reconciliation of Non-GAAP Operating Income and Non-GAAP Operating Margin

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

March 27, 2026

 

 

June 27, 2025

 

 

(Dollars in thousands)

 

GAAP Operating Income (Loss)

 

$

25,467

 

 

$

5,410

 

 

$

(2,740

)

GAAP Operating Margin (% of net sales)

 

 

9.8

%

 

 

2.2

%

 

 

(1.3

)%

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

9

 

 

 

496

 

 

 

130

 

Impairment of assets held for sale

 

 

 

 

 

6,590

 

 

 

 

Purchased intangible amortization

 

 

5,630

 

 

 

5,653

 

 

 

5,627

 

Restructuring costs

 

 

660

 

 

 

5,027

 

 

 

3,020

 

Stock-based compensation(1)

 

 

17,205

 

 

 

10,647

 

 

 

10,762

 

Other costs(2)

 

 

1,429

 

 

 

4,026

 

 

 

5,873

 

Total Non-GAAP Adjustments

 

$

24,933

 

 

$

32,439

 

 

$

25,412

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Income

 

$

50,400

 

 

$

37,849

 

 

$

22,672

 

Non-GAAP Operating Margin (% of net sales)

 

 

19.4

%

 

 

15.6

%

 

 

11.1

%

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP stock-based compensation charges are stock-based compensation expense and related payroll tax effects.

 

(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 


Reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

March 27, 2026

 

 

June 27, 2025

 

 

(Dollars in thousands)

 

GAAP Net Income (Loss)

 

$

15,919

 

 

$

(16,436

)

 

$

(13,162

)

GAAP Net Income (Loss) Margin (% of net sales)

 

 

6.1

%

 

 

(6.8

)%

 

 

(6.5

)%

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

4,384

 

 

 

5,136

 

 

 

6,359

 

Interest income

 

 

(405

)

 

 

(269

)

 

 

(234

)

Income tax provision

 

 

1,506

 

 

 

13,749

 

 

 

3,169

 

Depreciation & amortization

 

 

16,867

 

 

 

17,765

 

 

 

16,216

 

EBITDA

 

$

38,271

 

 

$

19,945

 

 

$

12,348

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

9

 

 

 

496

 

 

 

130

 

Impairment of assets held for sale

 

 

 

 

 

6,590

 

 

 

 

Restructuring costs

 

 

662

 

 

 

4,830

 

 

 

2,824

 

Stock-based compensation(1)

 

 

17,205

 

 

 

10,647

 

 

 

10,762

 

Other costs(2)

 

 

5,902

 

 

 

7,184

 

 

 

7,304

 

Adjusted EBITDA

 

$

62,049

 

 

$

49,692

 

 

$

33,368

 

Adjusted EBITDA Margin (% of net sales)

 

 

23.9

%

 

 

20.4

%

 

 

16.4

%

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP stock-based compensation charges are stock-based compensation expense and related payroll tax effects.

 

(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 

Reconciliation of Non-GAAP Profit before Tax

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

March 27, 2026

 

 

June 27, 2025

 

 

(Dollars in thousands)

 

GAAP Income (Loss) before Income Taxes

 

$

17,425

 

 

$

(2,687

)

 

$

(9,993

)

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

9

 

 

 

496

 

 

 

130

 

Transaction-related interest

 

 

225

 

 

 

225

 

 

 

860

 

Impairment of assets held for sale

 

 

 

 

 

6,590

 

 

 

 

Purchased intangible amortization

 

 

5,630

 

 

 

5,653

 

 

 

5,627

 

Restructuring costs

 

 

662

 

 

 

5,074

 

 

 

3,020

 

Stock-based compensation(1)

 

 

17,205

 

 

 

10,647

 

 

 

10,762

 

Other costs(2)

 

 

5,941

 

 

 

7,718

 

 

 

7,304

 

Total Non-GAAP Adjustments

 

$

29,672

 

 

$

36,403

 

 

$

27,703

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Profit before Tax

 

$

47,097

 

 

$

33,716

 

 

$

17,710

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP stock-based compensation charges are stock-based compensation expense and related payroll tax effects.

 

(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 

Reconciliation of Non-GAAP Income Tax Provision and Non-GAAP Effective Tax Rate

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

March 27, 2026

 

 

June 27, 2025

 

 

(Dollars in thousands)

 

GAAP Income Tax Provision

 

$

1,506

 

 

$

13,749

 

 

$

3,169

 

GAAP effective tax rate

 

 

8.6

%

 

 

(511.7

)%

 

 

(31.7

)%

 

 

 

 

 

 

 

 

 

 

Tax effect of adjustments to GAAP results

 

 

3,071

 

 

 

(11,642

)

 

 

(1,483

)

 

 

 

 

 

 

 

 

 

 

Non-GAAP Income Tax Provision

 

$

4,577

 

 

$

2,107

 

 

$

1,686

 

Non-GAAP effective tax rate

 

 

9.7

%

 

 

6.2

%

 

 

9.5

%

 

 


Reconciliation of Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc. and Non-GAAP Earnings per Share

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

March 27, 2026

 

 

June 27, 2025

 

 

(Dollars in thousands)

 

GAAP Net Income (Loss) Attributable to Allegro MicroSystems, Inc.(1)

 

$

15,871

 

 

$

(16,488

)

 

$

(13,227

)

GAAP Basic weighted average common shares

 

 

185,806,543

 

 

 

185,309,271

 

 

 

184,587,027

 

GAAP Diluted weighted average common shares

 

 

187,770,061

 

 

 

185,309,271

 

 

 

184,587,027

 

GAAP Basic Income (Loss) per Share

 

$

0.09

 

 

$

(0.09

)

 

$

(0.07

)

GAAP Diluted Income (Loss) per Share

 

$

0.08

 

 

$

(0.09

)

 

$

(0.07

)

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

9

 

 

 

496

 

 

 

130

 

Transaction-related interest

 

 

225

 

 

 

225

 

 

 

860

 

Impairment of assets held for sale

 

 

 

 

 

6,590

 

 

 

 

Purchased intangible amortization

 

 

5,630

 

 

 

5,653

 

 

 

5,627

 

Restructuring costs

 

 

662

 

 

 

5,074

 

 

 

3,020

 

Stock-based compensation(2)

 

 

17,205

 

 

 

10,647

 

 

 

10,762

 

Other costs(3)

 

 

5,941

 

 

 

7,718

 

 

 

7,304

 

Total Non-GAAP Adjustments

 

 

29,672

 

 

 

36,403

 

 

 

27,703

 

Tax effect of adjustments to GAAP results(4)

 

 

(3,071

)

 

 

11,642

 

 

 

1,483

 

Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc.

 

$

42,472

 

 

$

31,557

 

 

$

15,959

 

Basic weighted average common shares

 

 

185,806,543

 

 

 

185,309,271

 

 

 

184,587,027

 

Diluted weighted average common shares

 

 

187,770,061

 

 

 

187,134,641

 

 

 

185,416,258

 

Non-GAAP Basic Earnings per Share

 

$

0.23

 

 

$

0.17

 

 

$

0.09

 

Non-GAAP Diluted Earnings per Share

 

$

0.23

 

 

$

0.17

 

 

$

0.09

 

 

 

 

 

 

 

 

 

 

 

(1) GAAP Net Income (Loss) Attributable to Allegro MicroSystems, Inc. represents GAAP Net Income (Loss) adjusted for Net Income Attributable to non-controlling interests.

 

(2) Included in non-GAAP stock-based compensation charges are stock-based compensation expense and related payroll tax effects.

 

(3) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consists of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, income (loss) in earnings of equity investments, and unrealized losses (gains) on investments.

 

(4) To calculate the tax effect of adjustments to GAAP results, the Company considers each Non-GAAP adjustment by tax jurisdiction, reverses all discrete items, non-recurring law changes to calculate an annual NG ETR. This NG ETR is then applied to Non-GAAP Profit Before Tax to arrive at the tax effect of adjustments to GAAP results.

 

 


 

Reconciliation of Non-GAAP Free Cash Flow and Non-GAAP Free Cash Flow as Percentage of Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

June 26, 2026

 

 

March 27, 2026

 

 

June 27, 2025

 

 

(Dollars in thousands)

 

GAAP Operating Cash Flow

 

$

21,989

 

 

$

35,714

 

 

$

61,618

 

GAAP Operating Cash Flow (% of net sales)

 

 

8.5

%

 

 

14.7

%

 

 

30.3

%

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(8,017

)

 

 

(17,016

)

 

 

(10,600

)

Non-GAAP Free Cash Flow

 

$

13,972

 

 

$

18,698

 

 

$

51,018

 

Non-GAAP Free Cash Flow (% of net sales)

 

 

5.4

%

 

 

7.7

%

 

 

25.1

%

Investor Contact:

Jalene Hoover

VP of Investor Relations & Corporate Communications

+1 (512) 751-6526

jhoover@allegromicro.com